Maze Therapeutics (MAZE) Other Non-Current Assets (2024 - 2026)

Maze Therapeutics has disclosed Other Non-Current Assets across 3 years of filings, most recently posting $1.1 million for Q1 2026.

• Other Non-Current Assets for Q1 2026 came in at $1.1 million, up 1.01% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.1 million (up 1.01% YoY), and the FY2025 annual result was $3.0 million, down 61.25% from the prior year.
• Other Non-Current Assets came in at $1.1 million for Q1 2026 at Maze Therapeutics, down from $3.0 million in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $7.9 million in Q4 2024 to a low of $1.1 million in Q1 2025.
• The 3-year median for Other Non-Current Assets is $1.1 million (2025), against an average of $2.5 million.
• Across the five-year window, Other Non-Current Assets slumped 61.25% in 2025 and climbed 1.01% in 2026, its largest moves.
• Maze Therapeutics' Other Non-Current Assets stood at $7.9 million in 2024, then plunged by 61.25% to $3.0 million in 2025, then plunged by 63.91% to $1.1 million in 2026.
• The last three Other Non-Current Assets figures came in at $1.1 million (Q1 2026), $3.0 million (Q4 2025), and $1.1 million (Q3 2025), per Business Quant data.